Company page
Aim Immunotech Inc.
Aim Immunotech Inc. is a public company traded under the ticker AIM in the American market. The company has a market capitalization of approximately $10.5 million. Aim Immunotech focuses on developing innovative immunotherapy solutions.
- Ticker
- AIM:AMEX
- Asset type
- Stock
- Market cap
- $10.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- AMEX
- Currency
- USD